Cristina Falcó

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

Rafael Giner Seguí, Amparo Estellés, Yolanda Mira et al. · British Journal of Haematology · 2000 · 100 citations

Medicine, Genetics, Hematology +15

Quantitative Real-Time Reverse Transcription-PCR Assay for Urokinase Plasminogen Activator, Plasminogen Activator Inhibitor Type 1, and Tissue Metalloproteinase Inhibitor Type 1 Gene Expressions in Primary Breast Cancer

Remedios Castelló, Amparo Estellés, Carlos Vázquez et al. · Clinical Chemistry · 2002 · 85 citations · Full text

Medicine, Molecular Biology, Oncology +17

Thrombin‐activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system

Esther Zorio, Remedios Castelló, Cristina Falcó et al. · British Journal of Haematology · 2003 · 75 citations

Medicine, Cardiology, Genetics +16

Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome

Achille Tolino, Valentina Gambardella, Carmela Caccavale et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2004 · 69 citations

Medicine, Endocrinology, Gynecology +13

Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk

Yolanda Mira, José Mateo, Cristina Falcó et al. · Thrombosis and Haemostasis · 2003 · 61 citations

Medicine, Genetics, Hematology +17